Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study

Daily life blood pressure, cardiac damage, and prognosis

Giuseppe Mancia, Michele Bombelli, Giovanni Corrao, Rita Facchetti, Fabiana Madotto, Cristina Giannattasio, Fosca Quarti Trevano, Guido Grassi, Alberto Zanchetti, Roberto Sega

Research output: Contribution to journalArticle

194 Citations (Scopus)

Abstract

The prevalence of the metabolic syndrome (National Cholesterol Education Program Adult Treatment Panel III criteria) and its relationships with daily life blood pressures, cardiac damage, and prognosis were determined in 2013 subjects from a Northern Italian population aged 25 to 74 years. Home blood pressure, 24-hour blood pressure, and left ventricular mass index (echocardiography) were also measured. Cardiovascular and noncardiovascular deaths were registered over 148 months. Metabolic syndrome was found in 16.2% of the sample, an office blood pressure elevation being the most frequent (95.4%) and the blood glucose abnormality the least frequent (31.5%) component. There was in metabolic syndrome a frequent elevation in home and/or 24-hour average blood pressure, as well as a greater left ventricular mass index and prevalence of left ventricular hypertrophy, which was manifest even when data were adjusted for between-group differences, including blood pressure. The adjusted risk of cardiovascular and all-cause mortality was greater in metabolic syndrome subjects (+71.0% and +37.0%; P

Original languageEnglish
Pages (from-to)40-47
Number of pages8
JournalHypertension
Volume49
Issue number1
DOIs
Publication statusPublished - Jan 2007

Fingerprint

Blood Pressure
Left Ventricular Hypertrophy
Echocardiography
Blood Glucose
Cholesterol
Education
Mortality
Population
Therapeutics

Keywords

  • Blood pressure
  • Cardiac hypertrophy
  • Cardiovascular morbidity
  • Cardiovascular mortality
  • Metabolic syndrome

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study : Daily life blood pressure, cardiac damage, and prognosis. / Mancia, Giuseppe; Bombelli, Michele; Corrao, Giovanni; Facchetti, Rita; Madotto, Fabiana; Giannattasio, Cristina; Trevano, Fosca Quarti; Grassi, Guido; Zanchetti, Alberto; Sega, Roberto.

In: Hypertension, Vol. 49, No. 1, 01.2007, p. 40-47.

Research output: Contribution to journalArticle

Mancia, G, Bombelli, M, Corrao, G, Facchetti, R, Madotto, F, Giannattasio, C, Trevano, FQ, Grassi, G, Zanchetti, A & Sega, R 2007, 'Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: Daily life blood pressure, cardiac damage, and prognosis', Hypertension, vol. 49, no. 1, pp. 40-47. https://doi.org/10.1161/01.HYP.0000251933.22091.24
Mancia, Giuseppe ; Bombelli, Michele ; Corrao, Giovanni ; Facchetti, Rita ; Madotto, Fabiana ; Giannattasio, Cristina ; Trevano, Fosca Quarti ; Grassi, Guido ; Zanchetti, Alberto ; Sega, Roberto. / Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study : Daily life blood pressure, cardiac damage, and prognosis. In: Hypertension. 2007 ; Vol. 49, No. 1. pp. 40-47.
@article{abfe06136dfd444283e4960c834542de,
title = "Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: Daily life blood pressure, cardiac damage, and prognosis",
abstract = "The prevalence of the metabolic syndrome (National Cholesterol Education Program Adult Treatment Panel III criteria) and its relationships with daily life blood pressures, cardiac damage, and prognosis were determined in 2013 subjects from a Northern Italian population aged 25 to 74 years. Home blood pressure, 24-hour blood pressure, and left ventricular mass index (echocardiography) were also measured. Cardiovascular and noncardiovascular deaths were registered over 148 months. Metabolic syndrome was found in 16.2{\%} of the sample, an office blood pressure elevation being the most frequent (95.4{\%}) and the blood glucose abnormality the least frequent (31.5{\%}) component. There was in metabolic syndrome a frequent elevation in home and/or 24-hour average blood pressure, as well as a greater left ventricular mass index and prevalence of left ventricular hypertrophy, which was manifest even when data were adjusted for between-group differences, including blood pressure. The adjusted risk of cardiovascular and all-cause mortality was greater in metabolic syndrome subjects (+71.0{\%} and +37.0{\%}; P",
keywords = "Blood pressure, Cardiac hypertrophy, Cardiovascular morbidity, Cardiovascular mortality, Metabolic syndrome",
author = "Giuseppe Mancia and Michele Bombelli and Giovanni Corrao and Rita Facchetti and Fabiana Madotto and Cristina Giannattasio and Trevano, {Fosca Quarti} and Guido Grassi and Alberto Zanchetti and Roberto Sega",
year = "2007",
month = "1",
doi = "10.1161/01.HYP.0000251933.22091.24",
language = "English",
volume = "49",
pages = "40--47",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study

T2 - Daily life blood pressure, cardiac damage, and prognosis

AU - Mancia, Giuseppe

AU - Bombelli, Michele

AU - Corrao, Giovanni

AU - Facchetti, Rita

AU - Madotto, Fabiana

AU - Giannattasio, Cristina

AU - Trevano, Fosca Quarti

AU - Grassi, Guido

AU - Zanchetti, Alberto

AU - Sega, Roberto

PY - 2007/1

Y1 - 2007/1

N2 - The prevalence of the metabolic syndrome (National Cholesterol Education Program Adult Treatment Panel III criteria) and its relationships with daily life blood pressures, cardiac damage, and prognosis were determined in 2013 subjects from a Northern Italian population aged 25 to 74 years. Home blood pressure, 24-hour blood pressure, and left ventricular mass index (echocardiography) were also measured. Cardiovascular and noncardiovascular deaths were registered over 148 months. Metabolic syndrome was found in 16.2% of the sample, an office blood pressure elevation being the most frequent (95.4%) and the blood glucose abnormality the least frequent (31.5%) component. There was in metabolic syndrome a frequent elevation in home and/or 24-hour average blood pressure, as well as a greater left ventricular mass index and prevalence of left ventricular hypertrophy, which was manifest even when data were adjusted for between-group differences, including blood pressure. The adjusted risk of cardiovascular and all-cause mortality was greater in metabolic syndrome subjects (+71.0% and +37.0%; P

AB - The prevalence of the metabolic syndrome (National Cholesterol Education Program Adult Treatment Panel III criteria) and its relationships with daily life blood pressures, cardiac damage, and prognosis were determined in 2013 subjects from a Northern Italian population aged 25 to 74 years. Home blood pressure, 24-hour blood pressure, and left ventricular mass index (echocardiography) were also measured. Cardiovascular and noncardiovascular deaths were registered over 148 months. Metabolic syndrome was found in 16.2% of the sample, an office blood pressure elevation being the most frequent (95.4%) and the blood glucose abnormality the least frequent (31.5%) component. There was in metabolic syndrome a frequent elevation in home and/or 24-hour average blood pressure, as well as a greater left ventricular mass index and prevalence of left ventricular hypertrophy, which was manifest even when data were adjusted for between-group differences, including blood pressure. The adjusted risk of cardiovascular and all-cause mortality was greater in metabolic syndrome subjects (+71.0% and +37.0%; P

KW - Blood pressure

KW - Cardiac hypertrophy

KW - Cardiovascular morbidity

KW - Cardiovascular mortality

KW - Metabolic syndrome

UR - http://www.scopus.com/inward/record.url?scp=33847630752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847630752&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000251933.22091.24

DO - 10.1161/01.HYP.0000251933.22091.24

M3 - Article

VL - 49

SP - 40

EP - 47

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 1

ER -